Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Stonegate Investment Group LLC

Stonegate Investment Group LLC reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.7% in the 4th quarter, Holdings Channel reports. The firm owned 2,712 shares of the medical equipment provider’s stock after selling 103 shares during the quarter. Stonegate Investment Group LLC’s holdings in Intuitive Surgical were worth $1,416,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in ISRG. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical during the 4th quarter valued at $26,000. Godsey & Gibb Inc. boosted its position in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical during the third quarter valued at about $33,000. Decker Retirement Planning Inc. purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth about $36,000. Finally, Capital Performance Advisors LLP acquired a new position in shares of Intuitive Surgical in the third quarter worth about $38,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the sale, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. This represents a 42.84 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Jamie Samath sold 270 shares of the stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 42,265 shares of company stock worth $21,964,281. 0.90% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of brokerages have weighed in on ISRG. Barclays raised their price objective on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday. Robert W. Baird lifted their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Jefferies Financial Group boosted their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday. Finally, UBS Group lifted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Trading Down 1.8 %

Shares of NASDAQ ISRG opened at $573.48 on Tuesday. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The company has a market cap of $204.26 billion, a PE ratio of 92.20, a P/E/G ratio of 5.19 and a beta of 1.39. The stock has a 50 day simple moving average of $547.16 and a 200-day simple moving average of $505.21.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.